vs

Side-by-side financial comparison of Confluent, Inc. (CFLT) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

Confluent, Inc. is the larger business by last-quarter revenue ($314.8M vs $270.8M, roughly 1.2× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -25.2%, a 25.9% gap on every dollar of revenue. On growth, Confluent, Inc. posted the faster year-over-year revenue change (20.5% vs -16.5%). Confluent, Inc. produced more free cash flow last quarter ($41.7M vs $3.4M).

Confluent, Inc. is an American technology company headquartered in Mountain View, California. Confluent was founded by Jay Kreps, Jun Rao and Neha Narkhede on September 23, 2014, in order to commercialize an open-source streaming platform Apache Kafka, created by the same founders while working at LinkedIn in 2008 as a B2B infrastructure company. Confluent's products are the Confluent Cloud, Confluent Platform, Connectors, Apache Flink, Stream Governance and Confluent Hub.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

CFLT vs HCM — Head-to-Head

Bigger by revenue
CFLT
CFLT
1.2× larger
CFLT
$314.8M
$270.8M
HCM
Growing faster (revenue YoY)
CFLT
CFLT
+37.1% gap
CFLT
20.5%
-16.5%
HCM
Higher net margin
HCM
HCM
25.9% more per $
HCM
0.7%
-25.2%
CFLT
More free cash flow
CFLT
CFLT
$38.3M more FCF
CFLT
$41.7M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CFLT
CFLT
HCM
HCM
Revenue
$314.8M
$270.8M
Net Profit
$-79.2M
$2.0M
Gross Margin
74.7%
37.7%
Operating Margin
-31.5%
-13.2%
Net Margin
-25.2%
0.7%
Revenue YoY
20.5%
-16.5%
Net Profit YoY
10.0%
-83.6%
EPS (diluted)
$-0.23
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CFLT
CFLT
HCM
HCM
Q4 25
$314.8M
$270.8M
Q3 25
$298.5M
Q2 25
$282.3M
$277.7M
Q1 25
$271.1M
$324.5M
Q4 24
$261.2M
Q3 24
$250.2M
Q2 24
$235.0M
$305.7M
Q1 24
$217.2M
Net Profit
CFLT
CFLT
HCM
HCM
Q4 25
$-79.2M
$2.0M
Q3 25
$-66.5M
Q2 25
$-82.0M
$455.0M
Q1 25
$-67.6M
$11.9M
Q4 24
$-88.1M
Q3 24
$-74.1M
Q2 24
$-89.9M
$25.8M
Q1 24
$-93.0M
Gross Margin
CFLT
CFLT
HCM
HCM
Q4 25
74.7%
37.7%
Q3 25
74.2%
Q2 25
73.7%
0.1%
Q1 25
74.5%
48.0%
Q4 24
74.1%
Q3 24
74.5%
Q2 24
72.3%
41.1%
Q1 24
71.8%
Operating Margin
CFLT
CFLT
HCM
HCM
Q4 25
-31.5%
-13.2%
Q3 25
-27.9%
Q2 25
-34.2%
-1.3%
Q1 25
-37.3%
-5.0%
Q4 24
-40.5%
Q3 24
-37.4%
Q2 24
-46.1%
-9.0%
Q1 24
-51.3%
Net Margin
CFLT
CFLT
HCM
HCM
Q4 25
-25.2%
0.7%
Q3 25
-22.3%
Q2 25
-29.0%
163.8%
Q1 25
-24.9%
3.7%
Q4 24
-33.7%
Q3 24
-29.6%
Q2 24
-38.3%
8.4%
Q1 24
-42.8%
EPS (diluted)
CFLT
CFLT
HCM
HCM
Q4 25
$-0.23
$0.00
Q3 25
$-0.19
Q2 25
$-0.24
$0.52
Q1 25
$-0.20
$0.01
Q4 24
$-0.26
Q3 24
$-0.23
Q2 24
$-0.28
$0.03
Q1 24
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CFLT
CFLT
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$347.2M
$1.4B
Total DebtLower is stronger
$1.1B
$93.2M
Stockholders' EquityBook value
$1.2B
$1.2B
Total Assets
$3.0B
$1.8B
Debt / EquityLower = less leverage
0.94×
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CFLT
CFLT
HCM
HCM
Q4 25
$347.2M
$1.4B
Q3 25
$298.5M
Q2 25
$295.6M
$1.4B
Q1 25
$278.6M
$836.1M
Q4 24
$386.0M
Q3 24
$322.6M
Q2 24
$311.3M
$802.5M
Q1 24
$336.4M
Total Debt
CFLT
CFLT
HCM
HCM
Q4 25
$1.1B
$93.2M
Q3 25
$1.1B
Q2 25
$1.1B
$93.4M
Q1 25
$1.1B
$82.8M
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
$82.1M
Q1 24
$1.1B
Stockholders' Equity
CFLT
CFLT
HCM
HCM
Q4 25
$1.2B
$1.2B
Q3 25
$1.1B
Q2 25
$1.1B
$1.2B
Q1 25
$1.0B
$759.9M
Q4 24
$961.2M
Q3 24
$934.3M
Q2 24
$873.9M
$740.1M
Q1 24
$845.2M
Total Assets
CFLT
CFLT
HCM
HCM
Q4 25
$3.0B
$1.8B
Q3 25
$2.9B
Q2 25
$2.8B
$1.8B
Q1 25
$2.7B
$1.3B
Q4 24
$2.7B
Q3 24
$2.6B
Q2 24
$2.5B
$1.3B
Q1 24
$2.4B
Debt / Equity
CFLT
CFLT
HCM
HCM
Q4 25
0.94×
0.08×
Q3 25
0.98×
Q2 25
1.03×
0.08×
Q1 25
1.07×
0.11×
Q4 24
1.14×
Q3 24
1.17×
Q2 24
1.25×
0.11×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CFLT
CFLT
HCM
HCM
Operating Cash FlowLast quarter
$42.1M
$8.2M
Free Cash FlowOCF − Capex
$41.7M
$3.4M
FCF MarginFCF / Revenue
13.2%
1.2%
Capex IntensityCapex / Revenue
0.1%
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$60.7M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CFLT
CFLT
HCM
HCM
Q4 25
$42.1M
$8.2M
Q3 25
$30.8M
Q2 25
$18.1M
$-72.9M
Q1 25
$-26.8M
$40.3M
Q4 24
$35.2M
Q3 24
$15.6M
Q2 24
$8.6M
$-39.8M
Q1 24
$-26.0M
Free Cash Flow
CFLT
CFLT
HCM
HCM
Q4 25
$41.7M
$3.4M
Q3 25
$30.0M
Q2 25
$17.2M
$-82.2M
Q1 25
$-28.2M
$32.5M
Q4 24
$34.5M
Q3 24
$15.0M
Q2 24
$7.5M
$-49.9M
Q1 24
$-26.1M
FCF Margin
CFLT
CFLT
HCM
HCM
Q4 25
13.2%
1.2%
Q3 25
10.0%
Q2 25
6.1%
-29.6%
Q1 25
-10.4%
10.0%
Q4 24
13.2%
Q3 24
6.0%
Q2 24
3.2%
-16.3%
Q1 24
-12.0%
Capex Intensity
CFLT
CFLT
HCM
HCM
Q4 25
0.1%
1.8%
Q3 25
0.3%
Q2 25
0.3%
3.3%
Q1 25
0.5%
2.4%
Q4 24
0.3%
Q3 24
0.2%
Q2 24
0.5%
3.3%
Q1 24
0.1%
Cash Conversion
CFLT
CFLT
HCM
HCM
Q4 25
4.21×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
Q2 24
-1.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CFLT
CFLT

Confluent Cloud$169.4M54%
Post Contract Customer Support$93.8M30%
License$38.4M12%
Services$13.2M4%

HCM
HCM

Segment breakdown not available.

Related Comparisons